Allogene retains control of cancer therapy after arbitration ruling
Go back to Allogene retains control of cancer therapy after arbitration ruling| (NASDAQ: ALLO) | Delayed: 1.19 +0.07 (6.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.12 | 52 Week High | $ | |||
| Open | $1.16 | 52 Week Low | $ | |||
| Day High | $1.20 | P/E | N/A | |||
| Day Low | $1.12 | EPS | $ | |||
| Volume | 16,527,480 | |||||
| (NASDAQ: CLLS) | Delayed: 1.17 +0.08 (7.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $37.55 | |||
| Open | $1.14 | 52 Week Low | $16.35 | |||
| Day High | $1.25 | P/E | N/A | |||
| Day Low | $1.12 | EPS | $0.00 | |||
| Volume | 9,551 | |||||



